Part 1
Part 2
Part 3
Part 4
Part 5
Description
The global market for Biological Dural Patch was estimated to be worth US$ 717 million in 2025 and is projected to reach US$ 1047 million, growing at a CAGR of 5.6% from 2026 to 2032.
The potential shifts in the 2025 U.S. tariff framework pose substantial volatility risks to global markets. This report provides a comprehensive assessment of recent tariff adjustments and international strategic countermeasures on Biological Dural Patch cross-border industrial footprints, capital allocation patterns, regional economic interdependencies, and supply chain reconfigurations.
Biological Dural Patch Market Size(US$)
M= millions and B=billions

Biological dural patches are surgical repair materials made from animal tissues, such as bovine or porcine collagen. These patches are primarily used in neurosurgery to repair the dura mater and promote tissue healing by mimicking the natural structure of the dura. Biological dural patches are known for their high biocompatibility and ease of use in various surgical applications.
In 2025, global sales of Biological Dural Patch reached approximately 1,834 K Pcs, with an average global market price of around US$ 391/Pcs. Production capacity varies significantly among manufacturers, with gross profit margins ranging from approximately 80% to 95%.
The biological dural patch market is driven by both evolving clinical practice and advances in materials science. As neurosurgery shifts toward minimally invasive, endoscopic, and personalized approaches, surgeons increasingly favor materials that both reliably seal cerebrospinal fluid leaks and integrate into host tissue. Biological patches—owing to natural adhesion sites and their capacity to support matrix remodeling—are often preferred in scenarios where eventual tissue incorporation and reduced chronic foreign-body response are priorities. Differences in source material (allograft vs xenograft) and processing determine degradation profiles, mechanical strength, and immunocompatibility, making these attributes key points of product differentiation.
From a commercialization perspective, regulatory compliance and clinical evidence are central to market entry. Hospitals in more developed healthcare systems prioritize brands with long-term follow-up data and robust technical support; for many manufacturers, investing in clinical trials to demonstrate safety and efficacy is essential to gain trust and access premium segments. Supply chain factors—traceable raw materials, validated sterilization, and consistent production capacity—also heavily influence procurement and regional adoption. Cost-sensitive regions may favor more economical product tiers, prompting companies to adopt multi-tier strategies.
Future growth will come from combined advances: biofunctional modifications that better control resorption and direct cellular responses, composite patches that integrate hemostatic or antimicrobial functions, and geometries optimized for minimally invasive or endoscopic deployment. In parallel, customization enabled by imaging and surgical planning tools will open avenues for patient-specific patches. Despite technological progress, demonstrated long-term biocompatibility, immune response management, and systematic clinical evidence will remain the decisive factors for broad clinical adoption.
This report provides a comprehensive view of the global market for Biological Dural Patch, covering total sales volume, sales revenue, pricing, the market share and ranking of key companies, along with analyses by region & country, by Type, and by Application.
The Biological Dural Patch market size, estimations, and forecasts are presented in terms of sales volume (K Pcs) and revenue ($ millions), with 2025 as the base year and historical and forecast data from 2021 to 2032. The report combines quantitative and qualitative analysis to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current marketplace, and make informed business decisions regarding Biological Dural Patch.
Market Segmentation
Report Metric
Details
Report Title
Biological Dural Patch- Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
Forecasted Market Size in 2032
US$ 1047 million
CAGR(2026-2032)
5.6%
Market Size Available for Years
2026-2032
Global Biological Dural Patch Companies Covered
Integra LifeSciences
Tianxinfu Medical Appliance
B. Braun (Aesculap)
Johnson & Johnson
Baxter
Guanhao Biotech
Zhenghai Bio-Tech
Evergen
Regenity
Balance Medical
Bonsci Technology
Biosis Healing Biological
Global Biological Dural Patch Market, by Region
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Biological Dural Patch Market, Segment by Type
Bovine Derived Materials
Porcine Derived Materials
Global Biological Dural Patch Market, Segment by Application
Public Hospital
Private Hospital
Product Category
Suturable
Onlay
Market Segment
Cranial
Spinal
Forecast Units
Million USD
Report Coverage
Revenue and volume forecast, company share, competitive landscape, growth factors and trends
Chapter Outline
Chapter 1: Introduces the scope of the report and the global market size (value, volume, and price). It also summarizes market dynamics and Recent Developments; identifies key drivers and restraints; outlines challenges and risks for manufacturers; reviews relevant industry policies and U.S. tariff implications.
Chapter 2: Provides a detailed analysis of the Biological Dural Patch manufacturers' competitive landscape—including pricing, sales and revenue shares, Recent Developments plans, and mergers and acquisitions (M&A).
Chapter 3: Analyzes market segmentation by Type, presenting the size and growth potential of each segment to help readers identify blue-ocean opportunities.
Chapter 4: Analyzes market segmentation by Application, presenting the size and growth potential of each downstream segment to help readers identify blue-ocean opportunities.
Chapter 5: Presents Biological Dural Patch sales and revenue at the regional level. It offers a quantitative assessment of market size and growth potential by region and summarizes market development, future prospects, addressable space, and country-level market size worldwide.
Chapter 6: Presents Biological Dural Patch sales and revenue at the country level. It provides segmented data by Type and by Application for each country/region.
Chapter 7: Profiles key players, detailing the main companies' product sales, revenue, pricing, gross margin, product portfolios, Recent Developments, etc.
Chapter 8: Analyzes the industry value chain, including upstream suppliers and downstream applications/customers.
Chapter 9: Conclusion.
Table of Contents
1 Market Overview
1.1 Biological Dural Patch Product Introduction
1.2 Global Biological Dural Patch Market Size Forecast
1.2.1 Global Biological Dural Patch Sales Value (2021–2032)
1.2.2 Global Biological Dural Patch Sales Volume (2021–2032)
1.2.3 Global Biological Dural Patch Sales Price (2021–2032)
1.3 Biological Dural Patch Market Trends & Drivers
1.3.1 Biological Dural Patch Industry Trends
1.3.2 Biological Dural Patch Market Drivers & Opportunities
1.3.3 Biological Dural Patch Market Challenges
1.3.4 Biological Dural Patch Market Restraints
1.3.5 Impact of U.S. Tariffs
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Competitive Analysis by Company
2.1 Global Biological Dural Patch Players Revenue Ranking (2025)
2.2 Global Biological Dural Patch Revenue by Company (2021–2026)
2.3 Global Biological Dural Patch Sales Volume Ranking of Players (2025)
2.4 Global Biological Dural Patch Sales Volume by Company (2021–2026)
2.5 Global Biological Dural Patch Average Price by Company (2021–2026)
2.6 Key Manufacturers Biological Dural Patch Manufacturing Base and Headquarters
2.7 Key Manufacturers Biological Dural Patch Product Offerings
2.8 Key Manufacturers Start of Mass Production of Biological Dural Patch
2.9 Biological Dural Patch Market Competitive Analysis
2.9.1 Biological Dural Patch Market Concentration Rate (2021–2026)
2.9.2 Global 5 and 10 Largest Manufacturers by Biological Dural Patch Revenue in 2025
2.9.3 Global Companies by Tier (Tier 1, Tier 2, Tier 3), based on Biological Dural Patch revenue, 2025
2.10 Mergers & Acquisitions and Expansion
3 Segmentation Biological Dural Patch Market Classification
3.1 Introduction by Type
3.1.1 Bovine Derived Materials
3.1.2 Porcine Derived Materials
3.1.3 Global Biological Dural Patch Sales Value by Type
3.1.3.1 Global Biological Dural Patch Sales Value by Type (2021 vs 2025 vs 2032)
3.1.3.2 Global Biological Dural Patch Sales Value, by Type (2021–2032)
3.1.3.3 Global Biological Dural Patch Sales Value, by Type (%), 2021–2032
3.1.4 Global Biological Dural Patch Sales Volume by Type
3.1.4.1 Global Biological Dural Patch Sales Volume by Type (2021 vs 2025 vs 2032)
3.1.4.2 Global Biological Dural Patch Sales Volume, by Type (2021–2032)
3.1.4.3 Global Biological Dural Patch Sales Volume, by Type (%), 2021–2032
3.1.5 Global Biological Dural Patch Average Price by Type (2021–2032)
3.2 Introduction by Fixation Method
3.2.1 Suturable
3.2.2 Onlay
3.2.3 Global Biological Dural Patch Sales Value by Fixation Method
3.2.3.1 Global Biological Dural Patch Sales Value by Fixation Method (2021 vs 2025 vs 2032)
3.2.3.2 Global Biological Dural Patch Sales Value, by Fixation Method (2021–2032)
3.2.3.3 Global Biological Dural Patch Sales Value, by Fixation Method (%), 2021–2032
3.2.4 Global Biological Dural Patch Sales Volume by Fixation Method
3.2.4.1 Global Biological Dural Patch Sales Volume by Fixation Method (2021 vs 2025 vs 2032)
3.2.4.2 Global Biological Dural Patch Sales Volume, by Fixation Method (2021–2032)
3.2.4.3 Global Biological Dural Patch Sales Volume, by Fixation Method (%), 2021–2032
3.2.5 Global Biological Dural Patch Average Price by Fixation Method (2021–2032)
3.3 Introduction by Surgical Application Scenario
3.3.1 Cranial
3.3.2 Spinal
3.3.3 Global Biological Dural Patch Sales Value by Surgical Application Scenario
3.3.3.1 Global Biological Dural Patch Sales Value by Surgical Application Scenario (2021 vs 2025 vs 2032)
3.3.3.2 Global Biological Dural Patch Sales Value, by Surgical Application Scenario (2021–2032)
3.3.3.3 Global Biological Dural Patch Sales Value, by Surgical Application Scenario (%), 2021–2032
3.3.4 Global Biological Dural Patch Sales Volume by Surgical Application Scenario
3.3.4.1 Global Biological Dural Patch Sales Volume by Surgical Application Scenario (2021 vs 2025 vs 2032)
3.3.4.2 Global Biological Dural Patch Sales Volume, by Surgical Application Scenario (2021–2032)
3.3.4.3 Global Biological Dural Patch Sales Volume, by Surgical Application Scenario (%), 2021–2032
3.3.5 Global Biological Dural Patch Average Price by Surgical Application Scenario (2021–2032)
4 Segmentation by Application
4.1 Introduction by Application
4.1.1 Public Hospital
4.1.2 Private Hospital
4.2 Global Biological Dural Patch Sales Value by Application
4.2.1 Global Biological Dural Patch Sales Value by Application (2021 vs 2025 vs 2032)
4.2.2 Global Biological Dural Patch Sales Value, by Application (2021–2032)
4.2.3 Global Biological Dural Patch Sales Value, by Application (%), 2021–2032
4.3 Global Biological Dural Patch Sales Volume by Application
4.3.1 Global Biological Dural Patch Sales Volume by Application (2021 vs 2025 vs 2032)
4.3.2 Global Biological Dural Patch Sales Volume, by Application (2021–2032)
4.3.3 Global Biological Dural Patch Sales Volume, by Application (%), 2021–2032
4.4 Global Biological Dural Patch Average Price by Application (2021–2032)
5 Segmentation by Region
5.1 Global Biological Dural Patch Sales Value by Region
5.1.1 Global Biological Dural Patch Sales Value by Region: 2021 vs 2025 vs 2032
5.1.2 Global Biological Dural Patch Sales Value by Region (2021–2026)
5.1.3 Global Biological Dural Patch Sales Value by Region (2027–2032)
5.1.4 Global Biological Dural Patch Sales Value by Region (%), 2021–2032
5.2 Global Biological Dural Patch Sales Volume by Region
5.2.1 Global Biological Dural Patch Sales Volume by Region: 2021 vs 2025 vs 2032
5.2.2 Global Biological Dural Patch Sales Volume by Region (2021–2026)
5.2.3 Global Biological Dural Patch Sales Volume by Region (2027–2032)
5.2.4 Global Biological Dural Patch Sales Volume by Region (%), 2021–2032
5.3 Global Biological Dural Patch Average Price by Region (2021–2032)
5.4 North America
5.4.1 North America Biological Dural Patch Sales Value, 2021–2032
5.4.2 North America Biological Dural Patch Sales Value by Country (%), 2025 vs 2032
5.5 Europe
5.5.1 Europe Biological Dural Patch Sales Value, 2021–2032
5.5.2 Europe Biological Dural Patch Sales Value by Country (%), 2025 vs 2032
5.6 Asia Pacific
5.6.1 Asia Pacific Biological Dural Patch Sales Value, 2021–2032
5.6.2 Asia Pacific Biological Dural Patch Sales Value by Region (%), 2025 vs 2032
5.7 South America
5.7.1 South America Biological Dural Patch Sales Value, 2021–2032
5.7.2 South America Biological Dural Patch Sales Value by Country (%), 2025 vs 2032
5.8 Middle East & Africa
5.8.1 Middle East & Africa Biological Dural Patch Sales Value, 2021–2032
5.8.2 Middle East & Africa Biological Dural Patch Sales Value by Country (%), 2025 vs 2032
6 Segmentation by Key Countries/Regions
6.1 Key Countries/Regions Biological Dural Patch Sales Value Growth Trends, 2021 vs 2025 vs 2032
6.2 Key Countries/Regions Biological Dural Patch Sales Value and Sales Volume
6.2.1 Key Countries/Regions Biological Dural Patch Sales Value, 2021–2032
6.2.2 Key Countries/Regions Biological Dural Patch Sales Volume, 2021–2032
6.3 United States
6.3.1 United States Biological Dural Patch Sales Value, 2021–2032
6.3.2 United States Biological Dural Patch Sales Value by Type (%), 2025 vs 2032
6.3.3 United States Biological Dural Patch Sales Value by Application, 2025 vs 2032
6.4 Europe
6.4.1 Europe Biological Dural Patch Sales Value, 2021–2032
6.4.2 Europe Biological Dural Patch Sales Value by Type (%), 2025 vs 2032
6.4.3 Europe Biological Dural Patch Sales Value by Application, 2025 vs 2032
6.5 China
6.5.1 China Biological Dural Patch Sales Value, 2021–2032
6.5.2 China Biological Dural Patch Sales Value by Type (%), 2025 vs 2032
6.5.3 China Biological Dural Patch Sales Value by Application, 2025 vs 2032
6.6 Japan
6.6.1 Japan Biological Dural Patch Sales Value, 2021–2032
6.6.2 Japan Biological Dural Patch Sales Value by Type (%), 2025 vs 2032
6.6.3 Japan Biological Dural Patch Sales Value by Application, 2025 vs 2032
6.7 South Korea
6.7.1 South Korea Biological Dural Patch Sales Value, 2021–2032
6.7.2 South Korea Biological Dural Patch Sales Value by Type (%), 2025 vs 2032
6.7.3 South Korea Biological Dural Patch Sales Value by Application, 2025 vs 2032
6.8 Southeast Asia
6.8.1 Southeast Asia Biological Dural Patch Sales Value, 2021–2032
6.8.2 Southeast Asia Biological Dural Patch Sales Value by Type (%), 2025 vs 2032
6.8.3 Southeast Asia Biological Dural Patch Sales Value by Application, 2025 vs 2032
6.9 India
6.9.1 India Biological Dural Patch Sales Value, 2021–2032
6.9.2 India Biological Dural Patch Sales Value by Type (%), 2025 vs 2032
6.9.3 India Biological Dural Patch Sales Value by Application, 2025 vs 2032
7 Company Profiles
7.1 Integra LifeSciences
7.1.1 Integra LifeSciences Company Information
7.1.2 Integra LifeSciences Introduction and Business Overview
7.1.3 Integra LifeSciences Biological Dural Patch Sales, Revenue, Price and Gross Margin (2021–2026)
7.1.4 Integra LifeSciences Biological Dural Patch Product Offerings
7.1.5 Integra LifeSciences Recent Developments
7.2 Tianxinfu Medical Appliance
7.2.1 Tianxinfu Medical Appliance Company Information
7.2.2 Tianxinfu Medical Appliance Introduction and Business Overview
7.2.3 Tianxinfu Medical Appliance Biological Dural Patch Sales, Revenue, Price and Gross Margin (2021–2026)
7.2.4 Tianxinfu Medical Appliance Biological Dural Patch Product Offerings
7.2.5 Tianxinfu Medical Appliance Recent Developments
7.3 B. Braun (Aesculap)
7.3.1 B. Braun (Aesculap) Company Information
7.3.2 B. Braun (Aesculap) Introduction and Business Overview
7.3.3 B. Braun (Aesculap) Biological Dural Patch Sales, Revenue, Price and Gross Margin (2021–2026)
7.3.4 B. Braun (Aesculap) Biological Dural Patch Product Offerings
7.3.5 B. Braun (Aesculap) Recent Developments
7.4 Johnson & Johnson
7.4.1 Johnson & Johnson Company Information
7.4.2 Johnson & Johnson Introduction and Business Overview
7.4.3 Johnson & Johnson Biological Dural Patch Sales, Revenue, Price and Gross Margin (2021–2026)
7.4.4 Johnson & Johnson Biological Dural Patch Product Offerings
7.4.5 Johnson & Johnson Recent Developments
7.5 Baxter
7.5.1 Baxter Company Information
7.5.2 Baxter Introduction and Business Overview
7.5.3 Baxter Biological Dural Patch Sales, Revenue, Price and Gross Margin (2021–2026)
7.5.4 Baxter Biological Dural Patch Product Offerings
7.5.5 Baxter Recent Developments
7.6 Guanhao Biotech
7.6.1 Guanhao Biotech Company Information
7.6.2 Guanhao Biotech Introduction and Business Overview
7.6.3 Guanhao Biotech Biological Dural Patch Sales, Revenue, Price and Gross Margin (2021–2026)
7.6.4 Guanhao Biotech Biological Dural Patch Product Offerings
7.6.5 Guanhao Biotech Recent Developments
7.7 Zhenghai Bio-Tech
7.7.1 Zhenghai Bio-Tech Company Information
7.7.2 Zhenghai Bio-Tech Introduction and Business Overview
7.7.3 Zhenghai Bio-Tech Biological Dural Patch Sales, Revenue, Price and Gross Margin (2021–2026)
7.7.4 Zhenghai Bio-Tech Biological Dural Patch Product Offerings
7.7.5 Zhenghai Bio-Tech Recent Developments
7.8 Evergen
7.8.1 Evergen Company Information
7.8.2 Evergen Introduction and Business Overview
7.8.3 Evergen Biological Dural Patch Sales, Revenue, Price and Gross Margin (2021–2026)
7.8.4 Evergen Biological Dural Patch Product Offerings
7.8.5 Evergen Recent Developments
7.9 Regenity
7.9.1 Regenity Company Information
7.9.2 Regenity Introduction and Business Overview
7.9.3 Regenity Biological Dural Patch Sales, Revenue, Price and Gross Margin (2021–2026)
7.9.4 Regenity Biological Dural Patch Product Offerings
7.9.5 Regenity Recent Developments
7.10 Balance Medical
7.10.1 Balance Medical Company Information
7.10.2 Balance Medical Introduction and Business Overview
7.10.3 Balance Medical Biological Dural Patch Sales, Revenue, Price and Gross Margin (2021–2026)
7.10.4 Balance Medical Biological Dural Patch Product Offerings
7.10.5 Balance Medical Recent Developments
7.11 Bonsci Technology
7.11.1 Bonsci Technology Company Information
7.11.2 Bonsci Technology Introduction and Business Overview
7.11.3 Bonsci Technology Biological Dural Patch Sales, Revenue, Price and Gross Margin (2021–2026)
7.11.4 Bonsci Technology Biological Dural Patch Product Offerings
7.11.5 Bonsci Technology Recent Developments
7.12 Biosis Healing Biological
7.12.1 Biosis Healing Biological Company Information
7.12.2 Biosis Healing Biological Introduction and Business Overview
7.12.3 Biosis Healing Biological Biological Dural Patch Sales, Revenue, Price and Gross Margin (2021–2026)
7.12.4 Biosis Healing Biological Biological Dural Patch Product Offerings
7.12.5 Biosis Healing Biological Recent Developments
8 Industry Chain Analysis
8.1 Biological Dural Patch Industrial Chain
8.2 Biological Dural Patch Upstream Analysis
8.2.1 Key Raw Materials
8.2.2 Key Suppliers of Raw Materials
8.2.3 Manufacturing Cost Structure
8.3 Midstream Analysis
8.4 Downstream Analysis (Customer Analysis)
8.5 Sales Model and Sales Channelss
8.5.1 Biological Dural Patch Sales Model
8.5.2 Sales Channels
8.5.3 Biological Dural Patch Distributors
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.1.1 Research Programs/Design
10.1.1.2 Market Size Estimation
10.1.1.3 Market Breakdown and Data Triangulation
10.1.2 Data Source
10.1.2.1 Secondary Sources
10.1.2.2 Primary Sources
10.2 Author Details
10.3 Disclaimer
Table of Figures
List of Tables
Table 1. Biological Dural Patch Market Trends
Table 2. Biological Dural Patch Market Drivers & Opportunities
Table 3. Biological Dural Patch Market Challenges
Table 4. Biological Dural Patch Market Restraints
Table 5. Global Biological Dural Patch Revenue by Company (US$ Million), 2021–2026
Table 6. Global Biological Dural Patch Revenue Market Share by Company (2021–2026)
Table 7. Global Biological Dural Patch Sales Volume by Company (K Pcs), 2021–2026
Table 8. Global Biological Dural Patch Sales Volume Market Share by Company (2021–2026)
Table 9. Global Market Biological Dural Patch Price by Company (US$/Pc), 2021–2026
Table 10. Key Manufacturers Biological Dural Patch Manufacturing Base and Headquarters
Table 11. Key Manufacturers Biological Dural Patch Product Type
Table 12. Key Manufacturers Start of Mass Production of Biological Dural Patch
Table 13. Global Biological Dural Patch Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Top Manufacturers Market Share by Tier (Tier 1, Tier 2, Tier 3), based on Biological Dural Patch revenue, 2025
Table 15. Mergers & Acquisitions and Expansion Plans
Table 16. Global Biological Dural Patch Sales Value by Type: 2021 vs 2025 vs 2032 (US$ Million)
Table 17. Global Biological Dural Patch Sales Value by Type (US$ Million), 2021–2026
Table 18. Global Biological Dural Patch Sales Value by Type (US$ Million), 2027–2032
Table 19. Global Biological Dural Patch Sales Market Share in Value by Type (2021–2026)
Table 20. Global Biological Dural Patch Sales Market Share in Value by Type (2027–2032)
Table 21. Global Biological Dural Patch Sales Volume by Type: 2021 vs 2025 vs 2032 (K Pcs)
Table 22. Global Biological Dural Patch Sales Volume by Type (K Pcs), 2021–2026
Table 23. Global Biological Dural Patch Sales Volume by Type (K Pcs), 2027–2032
Table 24. Global Biological Dural Patch Sales Market Share in Volume by Type (2021–2026)
Table 25. Global Biological Dural Patch Sales Market Share in Volume by Type (2027–2032)
Table 26. Global Biological Dural Patch Price by Type (US$/Pc), 2021–2026
Table 27. Global Biological Dural Patch Price by Type (US$/Pc), 2027–2032
Table 28. Global Biological Dural Patch Sales Value by Fixation Method: 2021 vs 2025 vs 2032 (US$ Million)
Table 29. Global Biological Dural Patch Sales Value by Fixation Method (US$ Million), 2021–2026
Table 30. Global Biological Dural Patch Sales Value by Fixation Method (US$ Million), 2027–2032
Table 31. Global Biological Dural Patch Sales Market Share in Value by Fixation Method (2021–2026)
Table 32. Global Biological Dural Patch Sales Market Share in Value by Fixation Method (2027–2032)
Table 33. Global Biological Dural Patch Sales Volume by Fixation Method: 2021 vs 2025 vs 2032 (K Pcs)
Table 34. Global Biological Dural Patch Sales Volume by Fixation Method (K Pcs), 2021–2026
Table 35. Global Biological Dural Patch Sales Volume by Fixation Method (K Pcs), 2027–2032
Table 36. Global Biological Dural Patch Sales Market Share in Volume by Fixation Method (2021–2026)
Table 37. Global Biological Dural Patch Sales Market Share in Volume by Fixation Method (2027–2032)
Table 38. Global Biological Dural Patch Price by Fixation Method (US$/Pc), 2021–2026
Table 39. Global Biological Dural Patch Price by Fixation Method (US$/Pc), 2027–2032
Table 40. Global Biological Dural Patch Sales Value by Surgical Application Scenario: 2021 vs 2025 vs 2032 (US$ Million)
Table 41. Global Biological Dural Patch Sales Value by Surgical Application Scenario (US$ Million), 2021–2026
Table 42. Global Biological Dural Patch Sales Value by Surgical Application Scenario (US$ Million), 2027–2032
Table 43. Global Biological Dural Patch Sales Market Share in Value by Surgical Application Scenario (2021–2026)
Table 44. Global Biological Dural Patch Sales Market Share in Value by Surgical Application Scenario (2027–2032)
Table 45. Global Biological Dural Patch Sales Volume by Surgical Application Scenario: 2021 vs 2025 vs 2032 (K Pcs)
Table 46. Global Biological Dural Patch Sales Volume by Surgical Application Scenario (K Pcs), 2021–2026
Table 47. Global Biological Dural Patch Sales Volume by Surgical Application Scenario (K Pcs), 2027–2032
Table 48. Global Biological Dural Patch Sales Market Share in Volume by Surgical Application Scenario (2021–2026)
Table 49. Global Biological Dural Patch Sales Market Share in Volume by Surgical Application Scenario (2027–2032)
Table 50. Global Biological Dural Patch Price by Surgical Application Scenario (US$/Pc), 2021–2026
Table 51. Global Biological Dural Patch Price by Surgical Application Scenario (US$/Pc), 2027–2032
Table 52. Global Biological Dural Patch Sales Value by Application: 2021 vs 2025 vs 2032 (US$ Million)
Table 53. Global Biological Dural Patch Sales Value by Application (US$ Million), 2021–2026
Table 54. Global Biological Dural Patch Sales Value by Application (US$ Million), 2027–2032
Table 55. Global Biological Dural Patch Sales Market Share in Value by Application (2021–2026)
Table 56. Global Biological Dural Patch Sales Market Share in Value by Application (2027–2032)
Table 57. Global Biological Dural Patch Sales Volume by Application: 2021 vs 2025 vs 2032 (K Pcs)
Table 58. Global Biological Dural Patch Sales Volume by Application (K Pcs), 2021–2026
Table 59. Global Biological Dural Patch Sales Volume by Application (K Pcs), 2027–2032
Table 60. Global Biological Dural Patch Sales Market Share in Volume by Application (2021–2026)
Table 61. Global Biological Dural Patch Sales Market Share in Volume by Application (2027–2032)
Table 62. Global Biological Dural Patch Price by Application (US$/Pc), 2021–2026
Table 63. Global Biological Dural Patch Price by Application (US$/Pc), 2027–2032
Table 64. Global Biological Dural Patch Sales Value by Region, (US$ Million), 2021 vs 2025 vs 2032
Table 65. Global Biological Dural Patch Sales Value by Region (US$ Million), 2021–2026
Table 66. Global Biological Dural Patch Sales Value by Region (US$ Million), 2027–2032
Table 67. Global Biological Dural Patch Sales Value by Region (%), 2021–2026
Table 68. Global Biological Dural Patch Sales Value by Region (%), 2027–2032
Table 69. Global Biological Dural Patch Sales Volume by Region (K Pcs): 2021 vs 2025 vs 2032
Table 70. Global Biological Dural Patch Sales Volume by Region (K Pcs), 2021–2026
Table 71. Global Biological Dural Patch Sales Volume by Region (K Pcs), 2027–2032
Table 72. Global Biological Dural Patch Sales Volume by Region (%), 2021–2026
Table 73. Global Biological Dural Patch Sales Volume by Region (%), 2027–2032
Table 74. Global Biological Dural Patch Average Price by Region (US$/Pc), 2021–2026
Table 75. Global Biological Dural Patch Average Price by Region (US$/Pc), 2027–2032
Table 76. Key Countries/Regions Biological Dural Patch Sales Value Growth Trends, (US$ Million): 2021 vs 2025 vs 2032
Table 77. Key Countries/Regions Biological Dural Patch Sales Value, (US$ Million), 2021–2026
Table 78. Key Countries/Regions Biological Dural Patch Sales Value, (US$ Million), 2027–2032
Table 79. Key Countries/Regions Biological Dural Patch Sales Volume, (K Pcs), 2021–2026
Table 80. Key Countries/Regions Biological Dural Patch Sales Volume, (K Pcs), 2027–2032
Table 81. Integra LifeSciences Company Information
Table 82. Integra LifeSciences Introduction and Business Overview
Table 83. Integra LifeSciences Biological Dural Patch Sales (K Pcs), Revenue (US$ Million), Price (US$/Pc) and Gross Margin (2021–2026)
Table 84. Integra LifeSciences Biological Dural Patch Product Offerings
Table 85. Integra LifeSciences Recent Developments
Table 86. Tianxinfu Medical Appliance Company Information
Table 87. Tianxinfu Medical Appliance Introduction and Business Overview
Table 88. Tianxinfu Medical Appliance Biological Dural Patch Sales (K Pcs), Revenue (US$ Million), Price (US$/Pc) and Gross Margin (2021–2026)
Table 89. Tianxinfu Medical Appliance Biological Dural Patch Product Offerings
Table 90. Tianxinfu Medical Appliance Recent Developments
Table 91. B. Braun (Aesculap) Company Information
Table 92. B. Braun (Aesculap) Introduction and Business Overview
Table 93. B. Braun (Aesculap) Biological Dural Patch Sales (K Pcs), Revenue (US$ Million), Price (US$/Pc) and Gross Margin (2021–2026)
Table 94. B. Braun (Aesculap) Biological Dural Patch Product Offerings
Table 95. B. Braun (Aesculap) Recent Developments
Table 96. Johnson & Johnson Company Information
Table 97. Johnson & Johnson Introduction and Business Overview
Table 98. Johnson & Johnson Biological Dural Patch Sales (K Pcs), Revenue (US$ Million), Price (US$/Pc) and Gross Margin (2021–2026)
Table 99. Johnson & Johnson Biological Dural Patch Product Offerings
Table 100. Johnson & Johnson Recent Developments
Table 101. Baxter Company Information
Table 102. Baxter Introduction and Business Overview
Table 103. Baxter Biological Dural Patch Sales (K Pcs), Revenue (US$ Million), Price (US$/Pc) and Gross Margin (2021–2026)
Table 104. Baxter Biological Dural Patch Product Offerings
Table 105. Baxter Recent Developments
Table 106. Guanhao Biotech Company Information
Table 107. Guanhao Biotech Introduction and Business Overview
Table 108. Guanhao Biotech Biological Dural Patch Sales (K Pcs), Revenue (US$ Million), Price (US$/Pc) and Gross Margin (2021–2026)
Table 109. Guanhao Biotech Biological Dural Patch Product Offerings
Table 110. Guanhao Biotech Recent Developments
Table 111. Zhenghai Bio-Tech Company Information
Table 112. Zhenghai Bio-Tech Introduction and Business Overview
Table 113. Zhenghai Bio-Tech Biological Dural Patch Sales (K Pcs), Revenue (US$ Million), Price (US$/Pc) and Gross Margin (2021–2026)
Table 114. Zhenghai Bio-Tech Biological Dural Patch Product Offerings
Table 115. Zhenghai Bio-Tech Recent Developments
Table 116. Evergen Company Information
Table 117. Evergen Introduction and Business Overview
Table 118. Evergen Biological Dural Patch Sales (K Pcs), Revenue (US$ Million), Price (US$/Pc) and Gross Margin (2021–2026)
Table 119. Evergen Biological Dural Patch Product Offerings
Table 120. Evergen Recent Developments
Table 121. Regenity Company Information
Table 122. Regenity Introduction and Business Overview
Table 123. Regenity Biological Dural Patch Sales (K Pcs), Revenue (US$ Million), Price (US$/Pc) and Gross Margin (2021–2026)
Table 124. Regenity Biological Dural Patch Product Offerings
Table 125. Regenity Recent Developments
Table 126. Balance Medical Company Information
Table 127. Balance Medical Introduction and Business Overview
Table 128. Balance Medical Biological Dural Patch Sales (K Pcs), Revenue (US$ Million), Price (US$/Pc) and Gross Margin (2021–2026)
Table 129. Balance Medical Biological Dural Patch Product Offerings
Table 130. Balance Medical Recent Developments
Table 131. Bonsci Technology Company Information
Table 132. Bonsci Technology Introduction and Business Overview
Table 133. Bonsci Technology Biological Dural Patch Sales (K Pcs), Revenue (US$ Million), Price (US$/Pc) and Gross Margin (2021–2026)
Table 134. Bonsci Technology Biological Dural Patch Product Offerings
Table 135. Bonsci Technology Recent Developments
Table 136. Biosis Healing Biological Company Information
Table 137. Biosis Healing Biological Introduction and Business Overview
Table 138. Biosis Healing Biological Biological Dural Patch Sales (K Pcs), Revenue (US$ Million), Price (US$/Pc) and Gross Margin (2021–2026)
Table 139. Biosis Healing Biological Biological Dural Patch Product Offerings
Table 140. Biosis Healing Biological Recent Developments
Table 141. Key Raw Materials Lists
Table 142. Key Suppliers of Raw Materials Lists
Table 143. Biological Dural Patch Downstream Customers
Table 144. Biological Dural Patch Distributors List
Table 145. Research Programs/Design for This Report
Table 146. Key Data Information from Secondary Sources
Table 147. Key Data Information from Primary Sources
List of Figures
Figure 1. Biological Dural Patch Product Picture
Figure 2. Global Biological Dural Patch Sales Value, 2021 vs 2025 vs 2032 (US$ Million)
Figure 3. Global Biological Dural Patch Sales Value (US$ Million), 2021–2032
Figure 4. Global Biological Dural Patch Sales Volume (K Pcs), 2021–2032
Figure 5. Global Biological Dural Patch Sales Price (US$/Pc), 2021–2032
Figure 6. Biological Dural Patch Report Years Considered
Figure 7. Global Biological Dural Patch Players Revenue Ranking (US$ Million), 2025
Figure 8. Global Biological Dural Patch Sales Volume Ranking of Players (K Pcs), 2025
Figure 9. The 5 and 10 Largest Manufacturers in the World: Market Share by Biological Dural Patch Revenue in 2025
Figure 10. Biological Dural Patch Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2021 vs 2025
Figure 11. Bovine Derived Materials Picture
Figure 12. Porcine Derived Materials Picture
Figure 13. Global Biological Dural Patch Sales Value by Type (US$ Million), 2021 vs 2025 vs 2032
Figure 14. Global Biological Dural Patch Sales Value Market Share by Type, 2025 & 2032
Figure 15. Global Biological Dural Patch Sales Volume by Type (K Pcs), 2021 vs 2025 vs 2032
Figure 16. Global Biological Dural Patch Sales Volume Market Share by Type, 2025 & 2032
Figure 17. Global Biological Dural Patch Price by Type (US$/Pc), 2021–2032
Figure 18. Suturable Picture
Figure 19. Onlay Picture
Figure 20. Global Biological Dural Patch Sales Value by Fixation Method (US$ Million), 2021 vs 2025 vs 2032
Figure 21. Global Biological Dural Patch Sales Value Market Share by Fixation Method, 2025 & 2032
Figure 22. Global Biological Dural Patch Sales Volume by Fixation Method (K Pcs), 2021 vs 2025 vs 2032
Figure 23. Global Biological Dural Patch Sales Volume Market Share by Fixation Method, 2025 & 2032
Figure 24. Global Biological Dural Patch Price by Fixation Method (US$/Pc), 2021–2032
Figure 25. Cranial Picture
Figure 26. Spinal Picture
Figure 27. Global Biological Dural Patch Sales Value by Surgical Application Scenario (US$ Million), 2021 vs 2025 vs 2032
Figure 28. Global Biological Dural Patch Sales Value Market Share by Surgical Application Scenario, 2025 & 2032
Figure 29. Global Biological Dural Patch Sales Volume by Surgical Application Scenario (K Pcs), 2021 vs 2025 vs 2032
Figure 30. Global Biological Dural Patch Sales Volume Market Share by Surgical Application Scenario, 2025 & 2032
Figure 31. Global Biological Dural Patch Price by Surgical Application Scenario (US$/Pc), 2021–2032
Figure 32. Product Picture of Public Hospital
Figure 33. Product Picture of Private Hospital
Figure 34. Global Biological Dural Patch Sales Value by Application (US$ Million), 2021 vs 2025 vs 2032
Figure 35. Global Biological Dural Patch Sales Value Market Share by Application, 2025 & 2032
Figure 36. Global Biological Dural Patch Sales Volume by Application (K Pcs), 2021 vs 2025 vs 2032
Figure 37. Global Biological Dural Patch Sales Volume Market Share by Application, 2025 & 2032
Figure 38. Global Biological Dural Patch Price by Application (US$/Pc), 2021–2032
Figure 39. North America Biological Dural Patch Sales Value (US$ Million), 2021–2032
Figure 40. North America Biological Dural Patch Sales Value by Country (%), 2025 vs 2032
Figure 41. Europe Biological Dural Patch Sales Value (US$ Million), 2021–2032
Figure 42. Europe Biological Dural Patch Sales Value by Country (%), 2025 vs 2032
Figure 43. Asia Pacific Biological Dural Patch Sales Value (US$ Million), 2021–2032
Figure 44. Asia Pacific Biological Dural Patch Sales Value by Region (%), 2025 vs 2032
Figure 45. South America Biological Dural Patch Sales Value (US$ Million), 2021–2032
Figure 46. South America Biological Dural Patch Sales Value by Country (%), 2025 vs 2032
Figure 47. Middle East & Africa Biological Dural Patch Sales Value (US$ Million), 2021–2032
Figure 48. Middle East & Africa Biological Dural Patch Sales Value by Country (%), 2025 vs 2032
Figure 49. Key Countries/Regions Biological Dural Patch Sales Value (%), 2021–2032
Figure 50. Key Countries/Regions Biological Dural Patch Sales Volume (%), 2021–2032
Figure 51. United States Biological Dural Patch Sales Value (US$ Million), 2021–2032
Figure 52. United States Biological Dural Patch Sales Value by Type (%), 2025 vs 2032
Figure 53. United States Biological Dural Patch Sales Value by Application (%), 2025 vs 2032
Figure 54. Europe Biological Dural Patch Sales Value (US$ Million), 2021–2032
Figure 55. Europe Biological Dural Patch Sales Value by Type (%), 2025 vs 2032
Figure 56. Europe Biological Dural Patch Sales Value by Application (%), 2025 vs 2032
Figure 57. China Biological Dural Patch Sales Value (US$ Million), 2021–2032
Figure 58. China Biological Dural Patch Sales Value by Type (%), 2025 vs 2032
Figure 59. China Biological Dural Patch Sales Value by Application (%), 2025 vs 2032
Figure 60. Japan Biological Dural Patch Sales Value (US$ Million), 2021–2032
Figure 61. Japan Biological Dural Patch Sales Value by Type (%), 2025 vs 2032
Figure 62. Japan Biological Dural Patch Sales Value by Application (%), 2025 vs 2032
Figure 63. South Korea Biological Dural Patch Sales Value (US$ Million), 2021–2032
Figure 64. South Korea Biological Dural Patch Sales Value by Type (%), 2025 vs 2032
Figure 65. South Korea Biological Dural Patch Sales Value by Application (%), 2025 vs 2032
Figure 66. Southeast Asia Biological Dural Patch Sales Value (US$ Million), 2021–2032
Figure 67. Southeast Asia Biological Dural Patch Sales Value by Type (%), 2025 vs 2032
Figure 68. Southeast Asia Biological Dural Patch Sales Value by Application (%), 2025 vs 2032
Figure 69. India Biological Dural Patch Sales Value (US$ Million), 2021–2032
Figure 70. India Biological Dural Patch Sales Value by Type (%), 2025 vs 2032
Figure 71. India Biological Dural Patch Sales Value by Application (%), 2025 vs 2032
Figure 72. Biological Dural Patch Industrial Chain
Figure 73. Biological Dural Patch Manufacturing Cost Structure
Figure 74. Channels of Distribution (Direct Sales, and Distribution)
Figure 75. Bottom-up and Top-down Approaches for This Report
Figure 76. Data Triangulation
Figure 77. Key Executives InterviewedDescription
The global market for Biological Dural Patch was estimated to be worth US$ 717 million in 2025 and is projected to reach US$ 1047 million, growing at a CAGR of 5.6% from 2026 to 2032.
The potential shifts in the 2025 U.S. tariff framework pose substantial volatility risks to global markets. This report provides a comprehensive assessment of recent tariff adjustments and international strategic countermeasures on Biological Dural Patch cross-border industrial footprints, capital allocation patterns, regional economic interdependencies, and supply chain reconfigurations.
Biological dural patches are surgical repair materials made from animal tissues, such as bovine or porcine collagen. These patches are primarily used in neurosurgery to repair the dura mater and promote tissue healing by mimicking the natural structure of the dura. Biological dural patches are known for their high biocompatibility and ease of use in various surgical applications.
In 2025, global sales of Biological Dural Patch reached approximately 1,834 K Pcs, with an average global market price of around US$ 391/Pcs. Production capacity varies significantly among manufacturers, with gross profit margins ranging from approximately 80% to 95%.
The biological dural patch market is driven by both evolving clinical practice and advances in materials science. As neurosurgery shifts toward minimally invasive, endoscopic, and personalized approaches, surgeons increasingly favor materials that both reliably seal cerebrospinal fluid leaks and integrate into host tissue. Biological patches—owing to natural adhesion sites and their capacity to support matrix remodeling—are often preferred in scenarios where eventual tissue incorporation and reduced chronic foreign-body response are priorities. Differences in source material (allograft vs xenograft) and processing determine degradation profiles, mechanical strength, and immunocompatibility, making these attributes key points of product differentiation.
From a commercialization perspective, regulatory compliance and clinical evidence are central to market entry. Hospitals in more developed healthcare systems prioritize brands with long-term follow-up data and robust technical support; for many manufacturers, investing in clinical trials to demonstrate safety and efficacy is essential to gain trust and access premium segments. Supply chain factors—traceable raw materials, validated sterilization, and consistent production capacity—also heavily influence procurement and regional adoption. Cost-sensitive regions may favor more economical product tiers, prompting companies to adopt multi-tier strategies.
Future growth will come from combined advances: biofunctional modifications that better control resorption and direct cellular responses, composite patches that integrate hemostatic or antimicrobial functions, and geometries optimized for minimally invasive or endoscopic deployment. In parallel, customization enabled by imaging and surgical planning tools will open avenues for patient-specific patches. Despite technological progress, demonstrated long-term biocompatibility, immune response management, and systematic clinical evidence will remain the decisive factors for broad clinical adoption.
This report provides a comprehensive view of the global market for Biological Dural Patch, covering total sales volume, sales revenue, pricing, the market share and ranking of key companies, along with analyses by region & country, by Type, and by Application.
The Biological Dural Patch market size, estimations, and forecasts are presented in terms of sales volume (K Pcs) and revenue ($ millions), with 2025 as the base year and historical and forecast data from 2021 to 2032. The report combines quantitative and qualitative analysis to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current marketplace, and make informed business decisions regarding Biological Dural Patch.
Market Segmentation
Chapter Outline
Chapter 1: Introduces the scope of the report and the global market size (value, volume, and price). It also summarizes market dynamics and Recent Developments; identifies key drivers and restraints; outlines challenges and risks for manufacturers; reviews relevant industry policies and U.S. tariff implications.
Chapter 2: Provides a detailed analysis of the Biological Dural Patch manufacturers' competitive landscape—including pricing, sales and revenue shares, Recent Developments plans, and mergers and acquisitions (M&A).
Chapter 3: Analyzes market segmentation by Type, presenting the size and growth potential of each segment to help readers identify blue-ocean opportunities.
Chapter 4: Analyzes market segmentation by Application, presenting the size and growth potential of each downstream segment to help readers identify blue-ocean opportunities.
Chapter 5: Presents Biological Dural Patch sales and revenue at the regional level. It offers a quantitative assessment of market size and growth potential by region and summarizes market development, future prospects, addressable space, and country-level market size worldwide.
Chapter 6: Presents Biological Dural Patch sales and revenue at the country level. It provides segmented data by Type and by Application for each country/region.
Chapter 7: Profiles key players, detailing the main companies' product sales, revenue, pricing, gross margin, product portfolios, Recent Developments, etc.
Chapter 8: Analyzes the industry value chain, including upstream suppliers and downstream applications/customers.
Chapter 9: Conclusion.
Related Reports
The global Biological Dural Patch market was valued at US$ 302 million in 2023 and is anticipated to reach US$ 530.9 million by 2030, witnessing a CAGR of 7.5% during the forecast period 2024-2030.
Published: 2024-01-18
Pages: 96
USD 2900.00
(Single User License)
The global Biological Dural Patch market is projected to grow from US$ 344 million in 2024 to US$ 530.9 million by 2030, at a Compound Annual Growth Rate (CAGR) of 7.5% during the forecast period.
Published: 2024-04-09
Pages: 107
USD 4900.00
(Single User License)
The global market for Biological Dural Patch was valued at US$ 641 million in the year 2024 and is projected to reach a revised size of US$ 958 million by 2031, growing at a CAGR of 6.0% during the forecast period.
Published: 2025-09-21
Pages: 92
USD 2900.00
(Single User License)
The global market for Biological Dural Patch was estimated to be worth US$ 367 million in 2024 and is forecast to a readjusted size of US$ 605 million by 2031 with a CAGR of 7.5% during the forecast period 2025-2031.
Published: 2025-01-23
Pages: 122
USD 3950.00
(Single User License)
The global market for Biological Dural Patch was estimated to be worth US$ 641 million in 2024 and is forecast to a readjusted size of US$ 958 million by 2031 with a CAGR of 6.0% during the forecast period 2025-2031.
Published: 2025-09-21
Pages: 119
USD 3950.00
(Single User License)
The global Biological Dural Patch market is projected to grow from US$ 641 million in 2024 to US$ 958 million by 2031, at a CAGR of 6.0% (2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published: 2025-11-02
Pages: 155
USD 4900.00
(Single User License)
The global Biological Dural Patch market size was US$ 641 million in 2024 and is forecast to a readjusted size of US$ 958 million by 2031 with a CAGR of 6.0% during the forecast period 2025-2031.
Published: 2025-11-02
Pages: 92
USD 4250.00
(Single User License)
The global Biological Dural Patch market size was US$ 717 million in 2025 and is forecast to reach a readjusted size of US$ 1047 million by 2032 with a CAGR of 5.6% during the forecast period 2026-2032.
Published: 2026-03-08
Pages: 93
USD 4250.00
(Single User License)
The global Biological Dural Patch market was valued at US$ 717 million in 2025 and is anticipated to reach US$ 1047 million by 2032, at a CAGR of 5.6% from 2026 to 2032.
Published: 2026-04-17
Pages: 119
USD 2900.00
(Single User License)
The global Biological Dural Patch market is projected to grow from US$ 717 million in 2025 to US$ 1047 million by 2032, at a CAGR of 5.6% (2026-2032), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published: 2026-03-08
Pages: 151
USD 4900.00
(Single User License)
The global Biological Dural Patch market was valued at US$ 302 million in 2023 and is anticipated to reach US$ 530.9 million by 2030, witnessing a CAGR of 7.5% during the forecast period 2024-2030.
Published: 2024-01-18
Pages: 96
The global Biological Dural Patch market is projected to grow from US$ 344 million in 2024 to US$ 530.9 million by 2030, at a Compound Annual Growth Rate (CAGR) of 7.5% during the forecast period.
Published: 2024-04-09
Pages: 107
The global market for Biological Dural Patch was valued at US$ 641 million in the year 2024 and is projected to reach a revised size of US$ 958 million by 2031, growing at a CAGR of 6.0% during the forecast period.
Published: 2025-09-21
Pages: 92
The global market for Biological Dural Patch was estimated to be worth US$ 367 million in 2024 and is forecast to a readjusted size of US$ 605 million by 2031 with a CAGR of 7.5% during the forecast period 2025-2031.
Published: 2025-01-23
Pages: 122
The global market for Biological Dural Patch was estimated to be worth US$ 641 million in 2024 and is forecast to a readjusted size of US$ 958 million by 2031 with a CAGR of 6.0% during the forecast period 2025-2031.
Published: 2025-09-21
Pages: 119
The global Biological Dural Patch market is projected to grow from US$ 641 million in 2024 to US$ 958 million by 2031, at a CAGR of 6.0% (2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published: 2025-11-02
Pages: 155
The global Biological Dural Patch market size was US$ 641 million in 2024 and is forecast to a readjusted size of US$ 958 million by 2031 with a CAGR of 6.0% during the forecast period 2025-2031.
Published: 2025-11-02
Pages: 92
The global Biological Dural Patch market size was US$ 717 million in 2025 and is forecast to reach a readjusted size of US$ 1047 million by 2032 with a CAGR of 5.6% during the forecast period 2026-2032.
Published: 2026-03-08
Pages: 93
The global Biological Dural Patch market was valued at US$ 717 million in 2025 and is anticipated to reach US$ 1047 million by 2032, at a CAGR of 5.6% from 2026 to 2032.
Published: 2026-04-17
Pages: 119
The global Biological Dural Patch market is projected to grow from US$ 717 million in 2025 to US$ 1047 million by 2032, at a CAGR of 5.6% (2026-2032), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published: 2026-03-08
Pages: 151
USD 3950.00
USD 5925.00
USD 7900.00
Add to Cart
Buy Now
Competition
Key players, new entrants,acquisitions, mergers and expansions,development trends and challenges.
Industry Analysis
Rawmaterial, application, product type, demand,supply,downstream, supply chain etc.
Market Size
Capacity, production, sales, revenue, price, cost etc.
Customized Information
We can offer customized survey and information to meet ourclient's need.
Fastest report delivery service
More than 19 years of vast experience
Operation for 24 * 7 & 365 days
In-depth and comprehensive analysis
Professional and timely after-sales service
Owns large database